Tscan Therapeutics shares owned by Goldman Sachs Group
Quarter-by-quarter ownership of Tscan Therapeutics (TCRX) shares owned by Goldman Sachs Group
from 13F filings
Historical chart of Goldman Sachs Group investment in Tscan Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Tscan Therapeutics held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Tscan Therapeutics by Goldman Sachs Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $238k | 131k | 1.82 |
| 2025-03-31 | $235k | 170k | 1.38 |
| 2024-12-31 | $488k | 161k | 3.04 |
| 2024-09-30 | $790k | 159k | 4.98 |
| 2024-06-30 | $206k | 35k | 5.85 |
| 2024-03-31 | $2.1M | 260k | 7.94 |
| 2023-12-31 | $177k | 30k | 5.83 |
| 2021-09-30 | $96k | 12k | 8.33 |